Our lead drug is a targeted cancer drug that is shown to be 13 times more effective and have lower side effects than conventional chemotherapy. It has been used to treat 2 patients in a new trial at the Mayo Clinic with a fatal blood cancer. It worked in both patients and caused no side effects. We plan to license the drug or sell the company to a big pharma company after 15 more patients are treated.